A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
Four substudies did not meet pre-specified primary endpoints -- -- Post hoc analyses show setmelanotide achieved statistically significant BMI reductions in patients with obesity due to a heterozygous ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive data from a pre-specified Week 36 interim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results